SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-023812
Filing Date
2024-02-14
Accepted
2024-02-14 16:31:06
Documents
2
Group Members
ALEX NOAH INVESTORS, INC.JONATHAN I. COPEJOSHUA B. SCHEINFELDLINCOLN PARK CAPITAL, LLCROCKLEDGE CAPITAL CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm246286d4_sc13ga.htm SC 13G/A 105717
2 EXHIBIT 99.1 tm246286d4_ex99-1.htm EX-99.1 11219
  Complete submission text file 0001104659-24-023812.txt   118846
Mailing Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654
Business Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654 312-822-9300
Lincoln Park Capital Fund, LLC (Filed by) CIK: 0001592644 (see all company filings)

IRS No.: 010939472 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Subject) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90218 | Film No.: 24639116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)